Drug Profile
Befloxatone
Alternative Names: MD 370503Latest Information Update: 13 Sep 2000
Price :
$50
*
At a glance
- Originator Sanofi-Synthelabo
- Class Antidepressants; Anxiolytics; Oxazoles; Small molecules; Smoking cessation therapies
- Mechanism of Action Monoamine oxidase A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder; Smoking withdrawal
Most Recent Events
- 13 Sep 2000 Discontinued-II for Smoking withdrawal in Europe (Unknown route)
- 13 Sep 2000 Discontinued-II for Smoking withdrawal in USA (Unknown route)
- 13 Sep 2000 Discontinued-III for Anxiety disorders in European Union (Unknown route)